Cellular metabolism of myeloid cells in sepsis

被引:82
|
作者
Arts, Rob J. W.
Gresnigt, Mark S.
Joosten, Leo A. B.
Netea, Mihai G.
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands
基金
欧洲研究理事会;
关键词
glycolysis; epigenetics; endotoxin; glucose; fatty acid; FATTY-ACID OXIDATION; NUCLEAR HORMONE-RECEPTORS; CRITICALLY-ILL PATIENTS; NF-KAPPA-B; BLOOD MONONUCLEAR-CELLS; INHIBITS HMGB1 RELEASE; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; RAW; 264.7; CELLS; AMINO-ACID;
D O I
10.1189/jlb.4MR0216-066R
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In recent years, it has become appreciated that immune cells have different metabolic profiles depending on their activation status. During sepsis, circulating leukocytes go through a hyperinflammatory state, which can be accompanied or followed by defective antimicrobial defenses (also described as immune tolerance or paralysis). In this review, the modulation of different cellular metabolic pathways during sepsis in monocytes and macrophages will be discussed. Glycolysis is studied extensively in sepsis and is up-regulated in hyperinflammatory cells, whereas in immune tolerance, it is often down-regulated. Few data are available on other metabolic pathways in immune cells from patients with sepsis. The pentose phosphate pathway is up-regulated during acute hyperinflammatory responses, whereas fatty acid beta-oxidation is increased later during sepsis and is associated with an anti-inflammatory (M2) phenotype of macrophages. Within the amino acid metabolism we will discuss the most studiedmetabolites. Collectively, these data argue that exploration of the immunometabolic pathways in sepsis is an important area of research, and the targeting of metabolic pathways may represent a promising novel strategy as a therapy of sepsis.
引用
收藏
页码:151 / 164
页数:14
相关论文
共 50 条
  • [11] Myeloid-Derived Suppressor Cells in Sepsis
    Schrijver, Irene T.
    Theroude, Charlotte
    Roger, Thierry
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [12] Role of myeloid derived suppressor cells in sepsis
    Malavika, M.
    Sanju, S.
    Poorna, M. R.
    Priya, Veeraraghavan Vishnu
    Sidharthan, Neeraj
    Varma, Praveen
    Mony, Ullas
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 104
  • [13] Myeloid cells and the microenvironment, microorganisms and metabolism
    Bogdan, Christian
    Steinkasserer, Alexander
    IMMUNOBIOLOGY, 2015, 220 (02) : III - III
  • [14] Sepsis, cellular energy metabolism, and tissue adenosine triphosphate concentration
    Gutierrez, G
    CRITICAL CARE MEDICINE, 2000, 28 (07) : 2664 - 2665
  • [15] Dendritic and myeloid suppressor cells as immunosuppressive biomarkers in sepsis
    Trusevich, M.
    Titov, L.
    Gorbich, Y.
    Dubuske, L.
    ALLERGY, 2021, 76 : 184 - 184
  • [16] ICU and Sepsis: Role of Myeloid and Lymphocyte Immune Cells
    Wang, Anxiu
    Zhang, Su
    Peng, Guangming
    Tang, Yuanxu
    Yang, Yaopeng
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [17] Nfia deletion in myeloid cells blocks expansion of myeloid-derived suppressor cells during sepsis
    Dai, Jun
    Kumbhare, Ajinkya
    Williams, Danielle A.
    Youssef, Dima
    Yao, Zhi Q.
    McCall, Charles E.
    El Gazzar, Mohamed
    INNATE IMMUNITY, 2018, 24 (01) : 54 - 65
  • [18] Arginine metabolism in myeloid cells in health and disease
    Karadima, Eleftheria
    Chavakis, Triantafyllos
    Alexaki, Vasileia Ismini
    SEMINARS IN IMMUNOPATHOLOGY, 2025, 47 (01)
  • [19] Myeloid-derived suppressor cells in sepsis: friend or foe?
    Alex G. Cuenca
    Lyle L. Moldawer
    Intensive Care Medicine, 2012, 38 : 928 - 930
  • [20] Myeloid-derived suppressor cells control microbial sepsis
    Marc Derive
    Youcef Bouazza
    Corentine Alauzet
    Sébastien Gibot
    Intensive Care Medicine, 2012, 38 : 1040 - 1049